REALLY, revenue up 66%, expenses up 41%, loss after tax up 27% to $9M.
They are not getting traction with KP. It’s been over a year that they have been trying to interstate. They may have a great product with clinical utility but with the first bulk order customer they can’t Integrate systems for ordering and processes?
a really disappointing result. The SP has take. A hammering as a result. The only good thing is that they won’t need to raise funds for a while.
the sales force needs to get traction otherwise why are we paying them. It would seem to me that covid is causing issues generally - sure we can do in home testing, but if people aren’t going out to the doctor it’s irrelevant.
- Forums
- NZX - By Stock
- Latest Result
REALLY, revenue up 66%, expenses up 41%, loss after tax up 27%...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PEB (NZSX) to my watchlist
(20min delay)
|
|||||
Last
15.8¢ |
Change
0.003(1.94%) |
Mkt cap ! n/a |
Open | High | Low | Value | Volume |
15.6¢ | 16.4¢ | 15.6¢ | $35.83K | 223.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
0 | 12879 | 15.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.4¢ | 76943 | 0 |
Last trade - 11.00am 04/10/2024 (20 minute delay) ? |
Featured News
PEB (NZSX) Chart |